BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
In the CORALreef AddOn study, roughly 80% of high-risk patients achieved an LDL target of less than 55 mg/dL by 8 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results